N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide

C36H37BrN4O5 — CID 23817780

IUPACN-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide
SMILESC[C@@H](/C=C/CC(=O)N1CCC[C@H]1CO)[C@]1(O)C(=O)N(Cc2cccc(NC(=O)Cc3c[nH]c4ccccc34)c2)c2ccc(Br)cc21
InChIInChI=1S/C36H37BrN4O5/c1-23(7-4-13-34(44)40-16-6-10-28(40)22-42)36(46)30-19-26(37)14-15-32(30)41(35(36)45)21-24-8-5-9-27(17-24)39-33(43)18-25-20-38-31-12-3-2-11-29(25)31/h2-5,7-9,11-12,14-15,17,19-20,23,28,38,42,46H,6,10,13,16,18,21-22H2,1H3,(H,39,43)/b7-4+/t23-,28-,36+/m0/s1
InChIKeyUSMANQFGRPKIRZ-GJGZPYOXSA-N
MW685.62 g/mol
LogP5.41
Rot. Bonds10

About N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide

N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide (PubChem CID 23817780) has the molecular formula C36H37BrN4O5 and a molecular weight of 685.62 g/mol. Its IUPAC name is N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide.

Molecular Properties

Compound NameN-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide
PubChem CID23817780
Molecular FormulaC36H37BrN4O5
Molecular Weight685.62 g/mol
Exact Mass684.19
IUPAC NameN-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide
SMILESC[C@@H](/C=C/CC(=O)N1CCC[C@H]1CO)[C@]1(O)C(=O)N(Cc2cccc(NC(=O)Cc3c[nH]c4ccccc34)c2)c2ccc(Br)cc21
InChIInChI=1S/C36H37BrN4O5/c1-23(7-4-13-34(44)40-16-6-10-28(40)22-42)36(46)30-19-26(37)14-15-32(30)41(35(36)45)21-24-8-5-9-27(17-24)39-33(43)18-25-20-38-31-12-3-2-11-29(25)31/h2-5,7-9,11-12,14-15,17,19-20,23,28,38,42,46H,6,10,13,16,18,21-22H2,1H3,(H,39,43)/b7-4+/t23-,28-,36+/m0/s1
InChIKeyUSMANQFGRPKIRZ-GJGZPYOXSA-N
XLogP5.41
TPSA125.97 Ų
H-Bond Donors4
H-Bond Acceptors5
Rotatable Bonds10
Heavy Atoms46
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500685.62
LogP ≤ 55.41
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide?
The IUPAC name of N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide (CID 23817780) is N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide.
What is the SMILES notation for N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide?
The canonical SMILES for N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide is C[C@@H](/C=C/CC(=O)N1CCC[C@H]1CO)[C@]1(O)C(=O)N(Cc2cccc(NC(=O)Cc3c[nH]c4ccccc34)c2)c2ccc(Br)cc21.
What is the InChIKey of N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide?
The InChIKey is USMANQFGRPKIRZ-GJGZPYOXSA-N. The full InChI is InChI=1S/C36H37BrN4O5/c1-23(7-4-13-34(44)40-16-6-10-28(40)22-42)36(46)30-19-26(37)14-15-32(30)41(35(36)45)21-24-8-5-9-27(17-24)39-33(43)18-25-20-38-31-12-3-2-11-29(25)31/h2-5,7-9,11-12,14-15,17,19-20,23,28,38,42,46H,6,10,13,16,18,21-22H2,1H3,(H,39,43)/b7-4+/t23-,28-,36+/m0/s1.
What are the key properties of N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide?
N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide has a molecular weight of 685.62 g/mol, XLogP of 5.41, 10 rotatable bonds, 4 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-[[(3R)-5-bromo-3-hydroxy-3-[(E,2S)-6-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-6-oxohex-3-en-2-yl]-2-oxoindol-1-yl]methyl]phenyl]-2-(1H-indol-3-yl)acetamide is sourced from PubChem (CID 23817780), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).